· *UK biotech firm Synairgen surged as much as 552% on Monday after the company announced its experimental coronavirus drug helped curb the contraction of serious COVID-19 symptoms.*
· *The SNG001 drug cut the odds of a patient requiring ventilation or dying by 79% compared to those receiving a placebo, the company said.*
·...
UK biotech firm skyrockets 552% after drug lowers odds of serious COVID-19 symptoms
Business Insider
0 shares
1 views
You might like
Related news coverage
'Everybody is a genius in a bull market': Mark Cuban warns behavior around the stock market's current rally is eerily similar to the 1999 dot-com bubble
· *Tech stocks' rally through recent months is "so similar" to the dot-com bubble seen in the late 1990s, billionaire entrepreneur..
Business Insider